AlphaGrep UK Ltd Purchases 12,181 Shares of Align Technology, Inc. $ALGN

AlphaGrep UK Ltd bought a new position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 12,181 shares of the medical equipment provider’s stock, valued at approximately $1,656,000. Align Technology makes up approximately 0.5% of AlphaGrep UK Ltd’s portfolio, making the stock its 7th largest position.

Other hedge funds have also bought and sold shares of the company. State Street Corp increased its holdings in shares of Align Technology by 939.2% during the 3rd quarter. State Street Corp now owns 53,176,557 shares of the medical equipment provider’s stock worth $7,069,459,000 after acquiring an additional 48,059,533 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Align Technology by 638.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock valued at $629,469,000 after acquiring an additional 4,031,284 shares during the period. BlackRock Inc. bought a new stake in Align Technology in the 2nd quarter valued at $745,370,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its holdings in Align Technology by 3,162.7% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after purchasing an additional 2,033,451 shares during the last quarter. Finally, First Trust Advisors LP raised its stake in Align Technology by 2,551.4% during the third quarter. First Trust Advisors LP now owns 1,634,638 shares of the medical equipment provider’s stock worth $217,332,000 after acquiring an additional 1,572,987 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on ALGN shares. Raymond James Financial restated a “buy” rating on shares of Align Technology in a research report on Monday, October 5th. Mizuho lowered their price target on shares of Align Technology from $220.00 to $200.00 and set an “outperform” rating for the company in a report on Thursday, October 22nd. Evercore cut Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price target for the company. in a research note on Monday, October 5th. Piper Sandler cut their price objective on Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a report on Wednesday, October 21st. Finally, Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 9th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $193.08.

Check Out Our Latest Research Report on ALGN

Align Technology Price Performance

Align Technology stock opened at $155.13 on Friday. The stock’s 50 day moving average is $152.50 and its 200 day moving average is $168.54. Align Technology, Inc. has a one year low of $132.63 and a one year high of $200.43. The firm has a market cap of $10.93 billion, a P/E ratio of 22.58, a P/E/G ratio of 2.01 and a beta of 1.74.

Align Technology (NASDAQ:ALGN – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period in the prior year, the company posted $2.61 earnings per share. Align Technology’s revenue for the quarter was up 1.9% compared to the same quarter last year. Equities analysts anticipate that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.

Align Technology Company Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Recommended Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.